24 May 2013
Keywords: altana, daxas, filed, eu, approval, germany, ag
Article | 23 February 2004
Germany's Altana AG has submitted a registration dossier to the European Medicines Evaluation Agency for its respiratory drug Daxas
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 February 2004
16 February 2004
1 March 2004
23 May 2013
© 2013 thepharmaletter.com